All PlansAdministrativeLow impact
Voluntary nationwide recall: Zenzedi (Azurity - January)
UPMC Health Plan·Psychiatry, Neurology, Family Medicine +2 more·Pharmacy
Effective date
Jan 24, 2024
We identified it
Jun 20, 2026
Summary
Azurity Pharmaceuticals has issued a voluntary nationwide recall of Zenzedi (dextroamphetamine) 30 mg tablets due to contamination with antihistamine tablets. This is a drug safety recall that does not directly impact billing codes or reimbursement procedures.
Action Required
Immediately: Clinical staff should identify patients prescribed Zenzedi 30 mg tablets and verify they have not received recalled lot. Contact patients who may have received affected medication to return it to pharmacy and obtain replacement. No billing code changes required.